MCLR — Medclair AB Cashflow Statement
0.000.00%
- SEK195.51m
- SEK189.77m
- SEK52.08m
Annual cashflow statement for Medclair AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13 | -4.99 | -2.77 | -0.664 | 4.65 |
| Non-Cash Items | 5.11 | 5.37 | 5.5 | 1.11 | 5 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.776 | -11.8 | 2.54 | 2.78 | -2.66 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.68 | -11.5 | 5.26 | 3.23 | 7 |
| Capital Expenditures | -2.96 | -4.32 | -5.45 | -6.16 | -4.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.045 | — | 2.7 | 1.05 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.96 | -4.37 | -5.45 | -3.46 | -3.84 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 30.9 | -0.493 | -0.493 | -0.39 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19.2 | -16.3 | -0.687 | -0.618 | 3.16 |